Johnson & Johnson (NYSE:JNJ) is one of the best medical stocks to invest in according to billionaires. Johnson & Johnson announced on May 21 a collaboration with the Department of Health – Abu Dhabi (DOH) for the launch of a global program to develop an open surgical intelligence network. The Department of Health – Abu Dhabi (DOH) is the regulator of the healthcare sector in Abu Dhabi, UAE, and the collaboration establishes Abu Dhabi as the “first node” in a global infrastructure aimed at accelerating AI innovation for all stages of the surgery experience.
Johnson & Johnson further reported that by integrating its Polyphonic™ open digital ecosystem with the Department of Health – Abu Dhabi and technology partners, including Nvidia and Amazon Web Services, the initiative aims to deploy the Polyphonic Surgery application into Abu Dhabi’s intelligent health system, which would connect operating rooms across the emirate to a surgical intelligence system. Management also stated that the initiative aligns with the company’s endeavors to “shape the future of surgery across open, laparoscopic, and robotic surgery”.
Johnson & Johnson develops, manufactures, and sells products in the healthcare field. The company operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment focuses on various therapeutic areas, including oncology, infectious diseases, immunology, cardiovascular and metabolic diseases, and others. The MedTech segment includes an elaborate range of medical devices and products used in cardiovascular intervention, orthopedics, interventional solutions, surgery, and vision fields.
READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.
